United States · 
Who invested in Braveheart Bio?
Braveheart Bio's investors include Andreessen Horowitz, OrbiMed and Forbion Capital Partners.
United States · Series A startup
Who invested in Braveheart Bio
Funding summaryUpdated 26 Oct 2026
$185Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $185MNov 2025
- Investors
- 3
The rounds
- Nov 2025
Founders and team
From Braveheart Bio's own website: 5 on the team.
- Brittany de TempleSenior Vice President, Development Operations
- Michele AndersonChief Development Officer
- Paul RickeyChief Financial Officer
- Chris ViehbacherChair of the Board
- David LubnerBoard Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Braveheart Bio
How much has Braveheart Bio raised?
Braveheart Bio has raised $185M across 1 round since 2025.
When did Braveheart Bio last raise?
Braveheart Bio's most recent round was a Series A of $185M in Nov 2025.
What was Braveheart Bio's biggest round?
Its most recent round, $185M in Nov 2025, is also its largest on record.
Who backed Braveheart Bio first?
Braveheart Bio's first round on record, in Nov 2025, was backed by Andreessen Horowitz, OrbiMed and Forbion Capital Partners.
What stage is Braveheart Bio at?
Braveheart Bio's latest named round is a Series A, in Nov 2025.
Where is Braveheart Bio based?
Braveheart Bio is based in the United States.
Companies like Braveheart Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.